Tibet Cheezheng Tibetan Medicine Co., Ltd.

Symbol: 002287.SZ

SHZ

22.21

CNY

Market price today

  • 20.1008

    P/E Ratio

  • 0.2589

    PEG Ratio

  • 11.78B

    MRK Cap

  • 0.02%

    DIV Yield

Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287-SZ) Stock Split, History Data

Working capital analysis

In terms of working capital, Tibet Cheezheng Tibetan Medicine Co., Ltd. maintains a healthy position. The total current assets of the company are valued at $3194367199. This represents a growth rate of 0.061% compared to the previous year. Breaking down the current assets, the cash and investments are worth $403434169, exhibiting a growth rate of -7.802% year-on-year. The receivables, another significant portion of the current assets, are valued at $663537593. The year-on-year growth rate for receivables is -21.122%. The inventory, which forms a critical part of the assets, is valued at $156332923. This represents a healthy year-on-year growth of 22.351% On the liabilities side, the company's current liabilities total $1245217472. This reflects a growth rate of -8.449% over the previous year, indicating the company's financial obligations are well under control.

202320222021202020192018
Cash and investments
403.43
437.57
666.63
1829.90
1346.75
395.51
Receavebles
663.54
841.22
629.55
1034.53
686.59
575.68
Inventory
156.33
127.77
118.50
94.40
61.99
60.28
Other
8.02
246.56
337.74
11.71
7.75
457.40
Total Current Assets
3194.37
3192.42
2936.40
2970.54
2135.37
1488.87
Acc Payable
255.60
93.47
184.00
50.21
20.19
8.87
Short Term Debt
478.04
762.31
610.81
306.36
300.19
0.00
Other Current Liab
437.68
402.19
4.59
9.67
37.50
193.40
Current Liabilities
1245.22
1360.13
1307.98
761.96
654.13
202.28

Capital Structure

When examining the capital structure of Tibet Cheezheng Tibetan Medicine Co., Ltd., it is clear that the company manages a robust portfolio. The value of their total assets clocks in at $6765391354. When juxtaposed with the previous year, this marks a growth rate of 13.058%, showcasing the company's ability to steadily grow its asset base. Turning to liabilities, the company has total liabilities amounting to $2896084887. Compared to the prior year, this reflects a growth rate of 15.633%. The long-term debt forms a sizable part of these liabilities, coming in at $1077319882. Over the last year, the long-term debt has grown by 3.159%. On the asset side, the cash and equivalent reserves are worth $357241866. The year-on-year growth of these reserves is 130.270%. The company's common stock, another important asset, holds a value of $530173477, growing at a rate of -0.003% from the previous year. Finally, the company's retained earnings stand at $2201604950, marking a growth rate of 17.258% year-over-year. These earnings represent the profits that Tibet Cheezheng Tibetan Medicine Co., Ltd. has chosen to reinvest in the business rather than distribute as dividends.

Total Assets

$6,765.39

Total liabilities

$2,896,084,887.00

Long term debt

$1,077.32

Cash and eqv

$357,241,866.00

Goodwill

$0.00

Retained earnings

$2,201,604,950.00

Common stock

$365.00

Enterprise Value

$16.96

Historical dividend key summary

Tibet Cheezheng Tibetan Medicine Co., Ltd.'s dividend per share is $0.39, showing the earnings shared with shareholders per share. It has grown by -33.898% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.

YearsQ1Q2Q3Q4Total
20230.0000.0000.3900.0000.390
20220.0000.0000.5900.0000.590
20210.0000.0000.3400.0000.340
20200.0000.0000.3500.0000.350
20190.0000.0000.3140.0000.314
20180.0000.0000.3160.0000.316
20170.0000.0000.3000.0000.300
20160.0000.0000.3160.0000.316
20150.0000.3000.0000.0000.300
20140.0000.2700.0000.0000.270
20130.0000.2390.0000.0000.239
20120.0000.2160.0000.0000.216
20110.0000.2160.0000.0000.216
20100.0000.2390.0000.0000.239

Net earnings per share (EPS)

Tibet Cheezheng Tibetan Medicine Co., Ltd. has an EPS of $0.18, which signifies the profit allocated per share of common stock. With a growth rate of -83.636% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.

YearsQ1Q2Q3Q4Total
20240.18---0.18
20230.180.410.130.381.10
20220.160.270.240.210.88
20210.191.6600.121.97
20200.09240.330.20.150.77
20190.160.220.140.170.69
20180.150.210.110.140.61
20170.130.190.07280.180.57
20160.120.180.0760.170.55
20150.110.190.06690.140.51
20140.09240.150.08470.130.45
20130.08470.130.06930.110.39
20120.05390.130.04620.150.38
20110.04620.110.02310.140.32
20100.04620.10.04620.120.32
20090.04620.110.05390.10.31
2008--0.06930.10.17

Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) stock split history

Understanding the historical stock splits of Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on July 11, 2019 with a ratio of 1.298334:1. Throughout its history, the company has undergone 1 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.

DateSplit Ratio
11 July 20191.298334:1

Frequently Asked Question

What is the latest historical split date of the company?

The latest historical split date is N/A.

What is firm free cah flow per share (FCF per share)?

The free cah flow per share (FCF per share) is 1.281.

What is company revenue per share?

The company revenue per share is 0.271.

What are firm earnings per share?

The firm earnings per share is 0.872.

What is Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) ROIC (return on capital)?

Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) ROIC (return on capital) is 0.110.

What is dividend per share figure?

The dividend per share is 0.390

What is enterprise plowback ratio?

Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ) plowback ratio is N/A

What is firm enterprise value (EV)?

The enterprise value (EV) is 16.960

What is company debt to equity ratio?

The debt to equity ratio is 0.520

What are debt ratio numbers?

The debt ratio is 0.294

What is company price to sales ratio?

The price to sales ratio is 5.604